Hybrid closed-loop insulin delivery versus sensor-augmented pump therapy in children aged 6-12 years: a randomised, controlled, cross-over, non-inferiority trial.
- DOI
- 10.1016/s2589-7500(21)00271-5
- Published
- 2022 Mar
- Container
- The Lancet. Digital health
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s2589-7500-21-00271-5,
title = {Hybrid closed-loop insulin delivery versus sensor-augmented pump therapy in children aged 6-12 years: a randomised, controlled, cross-over, non-inferiority trial.},
author = {Kariyawasam D and Morin C and Casteels K and Le Tallec C and Sfez A and Godot C and Huneker E and Garrec N and Benhamou PY and Polak M and Charpentier G and Franc S and Beltrand J},
year = {2022},
journal = {The Lancet. Digital health},
doi = {10.1016/s2589-7500(21)00271-5},
url = {https://doi.org/10.1016/s2589-7500(21)00271-5}
}RIS
TY - JOUR TI - Hybrid closed-loop insulin delivery versus sensor-augmented pump therapy in children aged 6-12 years: a randomised, controlled, cross-over, non-inferiority trial. AU - Kariyawasam D AU - Morin C AU - Casteels K AU - Le Tallec C AU - Sfez A AU - Godot C AU - Huneker E AU - Garrec N AU - Benhamou PY AU - Polak M AU - Charpentier G AU - Franc S AU - Beltrand J PY - 2022 JO - The Lancet. Digital health DO - 10.1016/s2589-7500(21)00271-5 UR - https://doi.org/10.1016/s2589-7500(21)00271-5 ER -
APA
D, K., C, M., K, C., C, L. T., A, S., C, G., E, H., N, G., PY, B., M, P., G, C., S, F., & J, B. (2022). Hybrid closed-loop insulin delivery versus sensor-augmented pump therapy in children aged 6-12 years: a randomised, controlled, cross-over, non-inferiority trial.. The Lancet. Digital health. https://doi.org/10.1016/s2589-7500(21)00271-5
Source records
- pubmed · retrieved 2026-09-27T15:10:42.093Z